Brief: Granules Says Unit Gets USFDA Tentative Approval For Generic Amphetamine Extended-Release Orally Disintegrating Tablets
22/12/2025 02:40
Dec 22 (Reuters) - Granules India Ltd GRAN.NS: UNIT GETS USFDA TENTATIVE APPROVAL FOR GENERIC AMPHETAMINE EXTENDED-RELEASE ORALLY DISINTEGRATING TABLETS Source text: ID:nnAZN4RHVP3 Further company coverage: GRAN.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Granules India
See all newsGranules India profit surges as higher sales outweigh cost pressures
Brief: Granules India Q2 Consol Profit 1.82 Billion Rupees
Brief: Granules Says Incorporated Wholly Owned Subsidiary Triton Farmaceutica S.A. De C.V. In Mexico
Brief: Granules Promoter Group Pays 10.93 Billion Rupees For Preferential Issue
Granules India falls after key shareholder trims stake